Clinical Trials
12 trialsNCT06189833 2024-04-23
TAURUS
European Myeloma Network B.V.
Phase 2 Unknown
NCT05280275 2023-12-01
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible
Hellenic Society of Hematology
Phase 1/2 Unknown
NCT03695744 2023-07-10
Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma
Singapore General Hospital
Phase 2 Unknown
NCT04474938 2022-05-10
Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03669445 2020-07-30
IFM2018-01
University Hospital, Toulouse
Phase 2 Unknown
NCT04065308 2019-08-22
Dara_DCEP
Seoul National University Hospital
Phase 2 Unknown
NCT03992170 2019-06-20
DART4MM
Azienda Ospedaliera Universitaria Senese
Phase 2 Unknown
NCT03697655 2019-01-03
PREDATOR
Polish Myeloma Consortium
Phase 2 Unknown
NCT03746652 2018-11-23
DARIA
Hellenic Society of Hematology
Phase 2 Unknown
NCT03143036 2018-06-07
Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma
National University Hospital, Singapore
Phase 2 Unknown
NCT02955810 2018-03-29
CyBorD-Dara
National University of Ireland, Galway, Ireland
Phase 1 Unknown
NCT03475628 2018-03-23
REBUILD
Hellenic Society of Hematology
Phase 2 Unknown